Articles
Analysis and Perspectives on Valuation, Transaction Advisory, and Financial Topics
- Articles, Cryptoassets, Valuation, Whitepapers
An Update to Houlihan Capital’s July 2026 Review of ASU 2022-03 September 20, 2026 On September 9, 2026, the Financial Accounting Standards Board issued ASU
- Articles, News, SPACs, Whitepapers
The SPAC market in 2026 and the renewed case for independent fairness opinions The blank check structure has returned to the public markets on very
- 101 Guides, Articles, News, Valuation
When the Balance Sheet Becomes the Story A portfolio company loses its largest customer. Revenue falls sharply in the back half of the year, and
- Articles, Cryptoassets, News, Valuation, Whitepapers
The July 2026 proposal reinforces a market-participant approach that Houlihan Capital has applied to cryptoasset portfolios for years Executive Takeaway In 2022, the FASB issued
- 101 Guides, Articles, News, Valuation, Whitepapers
When the Mark Gets Questioned The moment arrives in different forms. An auditor returns to a fair value conclusion with a request for additional support
- 101 Guides, Articles, News, Valuation
Consider a professional services firm where three client relationships — each cultivated personally by the founder over fifteen years — account for 65% of annual
- Articles, Fairness Opinions, News, Whitepapers
The Role of a Fairness Opinion in a de-SPAC Transaction When a SPAC enters into a business combination agreement, its board is evaluating a transaction
- Articles, Financial Advisory, News, Valuation
Framing the Decision to Sell For many founder-owned businesses, a sale represents one of the most significant financial and strategic decisions an owner will make.
- Articles, Cannabis, News, Valuation
On April 22, 2026, the Acting Attorney General issued a final order reclassifying FDA-approved marijuana products and state-licensed medical marijuana from Schedule I to Schedule
Latest Articles
Have a Question?
Our team is available to discuss your specific situation or point you to the right resource.
- 312.450.8600
- info@houlihancapital.com